Mechanism of liver gene transfer by mechanical massage

被引:32
作者
Liu, F
Lei, J
Vollmer, R
Huang, L
机构
[1] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA
关键词
liver; gene transfer; naked DNA; non-viral vector; mechanism;
D O I
10.1016/j.ymthe.2003.12.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Many metabolic diseases are caused by defects in the metabolic pathways in the liver. Others result from the absence of specific proteins normally produced and secreted by the liver. Because these metabolic disorders are usually caused by single gene defect, they are ideal candidates for gene therapy. We have previously shown that mouse liver can be transfected by mechanically massaging the liver (MML) after intravenous injection of naked plasmid DNA. We now show a significant linear relationship between the level of liver gene expression and the venous blood pressure, supporting the idea that gene transfer by MML is due, at least in part, to pressure-mediated effect. Liver transfection could not be blocked by co-injection of excess irrelevant DNA or poly 1, suggesting that there is no involvement of receptors, including the scavenger receptor, in MML. Moreover, the level of gene expression could be further enhanced by a combination of MML and an increase in DNA retention-time in the liver. Persistence of gene expression could be significantly improved using an EBV-based plasmid vector. Our data suggest the mechanical massage produces transient membrane defects through which naked DNA can enter into the liver cells by simple diffusion.
引用
收藏
页码:452 / 457
页数:6
相关论文
共 34 条
[21]   Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA [J].
Liu, F ;
Song, YK ;
Liu, D .
GENE THERAPY, 1999, 6 (07) :1258-1266
[22]  
Lui VWY, 2001, J GENE MED, V3, P384
[23]   Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model [J].
Marshall, J ;
McEachern, KA ;
Kyros, JAC ;
Nietupski, JB ;
Budzinski, TL ;
Ziegler, RJ ;
Yew, NS ;
Sullivan, J ;
Scaria, A ;
van Rooijen, N ;
Barranger, JA ;
Cheng, SH .
MOLECULAR THERAPY, 2002, 6 (02) :179-189
[24]   A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice [J].
McCaffrey, AP ;
Meuse, L ;
Karimi, M ;
Contag, CH ;
Kay, MA .
HEPATOLOGY, 2003, 38 (02) :503-508
[25]   Gene expression - RNA interference in adult mice [J].
McCaffrey, AP ;
Meuse, L ;
Pham, TTT ;
Conklin, DS ;
Hannon, GJ ;
Kay, MA .
NATURE, 2002, 418 (6893) :38-39
[26]   Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo [J].
Miao, CH ;
Thompson, AR ;
Loeb, K ;
Ye, X .
MOLECULAR THERAPY, 2001, 3 (06) :947-957
[27]   Epstein-Barr virus plasmid model system for analyzing recombination in human cells [J].
Phillips, JE ;
Thyagarajan, B ;
Calos, MP .
PLASMID, 1999, 41 (03) :198-206
[28]  
Song YK, 2002, METHOD ENZYMOL, V346, P92
[29]   Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice [J].
Stoll, SM ;
Sclimenti, CR ;
Baba, EJ ;
Meuse, L ;
Kay, MA ;
Calos, MP .
MOLECULAR THERAPY, 2001, 4 (02) :122-129
[30]  
STRAUSS M, 1994, GENE THER, V1, P156